Kilitch Drugs (India) Limited's market cap is currently ₹5.39B. The company's EPS TTM is ₹12.132; its P/E ratio is 26.80; Kilitch Drugs (India) Limited is scheduled to report earnings on February 18, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	₹ 1.54B	₹ 1.40B	₹ 1.14B	₹ 685.23M	₹ 533.20M
Gross Profit	₹ 620.48M	₹ 648.40M	₹ 488.01M	₹ 312.16M	₹ 242.34M
Operating Income	₹ 208.05M	₹ 148.60M	₹ 100.16M	₹ 41.34M	₹ -8.44M
EBITDA	₹ 286.33M	₹ 206.50M	₹ 134.13M	₹ 79.85M	₹ 45.47M
Net Income	₹ 146.01M	₹ 104.48M	₹ 73.67M	₹ 36.71M	₹ 8.42M
Balance Sheet
Cash & Short-Term Investments	₹ 690.19M	₹ 591.98M	₹ 572.43M	₹ 488.49M	₹ 305.73M
Total Assets	₹ 2.40B	₹ 2.20B	₹ 2.10B	₹ 2.03B	₹ 1.43B
Total Debt	₹ 316.46M	₹ 221.94M	₹ 204.32M	₹ 148.04M	₹ 126.09M
Net Debt	₹ 127.36M	₹ 23.48M	₹ 104.22M	₹ 23.55M	₹ 98.47M
Total Liabilities	₹ 643.88M	₹ 689.41M	₹ 695.55M	₹ 736.97M	₹ 223.60M
Stockholders' Equity	₹ 1.76B	₹ 1.52B	₹ 1.39B	₹ 1.27B	₹ 1.18B
Cash Flow
Free Cash Flow	₹ -121.19M	₹ 23.25M	₹ -24.19M	₹ 93.61M	₹ -67.54M
Operating Cash Flow	₹ -56.69M	₹ 25.86M	₹ 57.83M	₹ 456.59M	₹ 37.45M
Investing Cash Flow	₹ -95.45M	₹ 114.66M	₹ -152.50M	₹ -375.69M	₹ -104.54M
Financing Cash Flow	₹ 133.10M	₹ -7.16M	₹ 70.28M	₹ 16.14M	₹ 15.65M

Currency in INR

Kilitch Drugs (India) Limited Earnings and Revenue History

Income Statement >

Kilitch Drugs (India) Limited Debt to Assets

Balance Sheet >

Kilitch Drugs (India) Limited Cash Flow

Cash Flow >

Kilitch Drugs (India) Limited Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing